Zantac -- also known as ranitidine -- was a popular heartburn drug until 2020, when the Food and Drug Administration ordered it removed from pharmacy shelves because of a potential cancer risk. While ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...

A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported.

An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...

If you go to your local pharmacy or convenience store, you won’t be able to find any Zantac or other products made out of ranitidine. At least, you shouldn’t. But it’s not because people are ...

Drug maker GSK plc (GSK, GSK.L) confirmed Wednesday that it has reached two confidential settlements in cases filed in California ...

She argued Zantac’s former active ingredient, ranitidine, formed the likely carcinogen NDMA over time or when stored in ...

Over 75,000 plaintiffs filed suit in Delaware Superior Court alleging that ranitidine, which several manufacturers market under the trade name Zantac, caused their cancer. More specifically ...

GSK announced on Wednesday that it has reached confidential settlements in two lawsuits filed in California State Court ...

(Reuters) - British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does not admit to any ...

The recent trial regarding the discontinued heartburn drug Zantac, which allegedly causes cancer, ended in a hung jury. The ...